Association of monocyte to lymphocyte ratio with length of stay in intensive care unit in neonatal apnea modified by treatment
- PMID: 40688223
- PMCID: PMC12268477
- DOI: 10.21037/tp-2025-21
Association of monocyte to lymphocyte ratio with length of stay in intensive care unit in neonatal apnea modified by treatment
Abstract
Background: Apnea is a common condition among neonates admitted to the intensive care unit (ICU), often leading to prolonged hospitalization and increased healthcare burden. This study aimed to investigate the association between monocyte to lymphocyte ratio (MLR) and length of stay (LOS) in the ICU among neonates diagnosed with apnea.
Methods: Data were extracted from the Medical Information Mart for Intensive Care III (MIMIC III) database. Collinearity analysis excluded variables with a variance inflation factor >2. Generalized additive models (GAM) explored the nonlinear relationship between MLR and ICU LOS. Three generalized linear models (GLMs) assessed associations between MLR and LOS, adjusting for various factors. Mediation analysis evaluated MLR's role between intraventricular hemorrhage (IVH)/caffeine/mechanical ventilation and LOS in the ICU.
Results: A total of 1,120 neonates with apnea were included in this study. Neonates in the high MLR group had a significantly longer LOS in the ICU compared to the low MLR group. GAM analysis indicated a non-linear relationship between MLR and LOS in the ICU. In adjusted GLM analyses, higher MLR levels were positively correlated with increased LOS in the ICU {β=5.576 [95% confidence interval (CI): 2.270, 8.881], P=0.001} and LOS in the hospital [β=5.529 (95% CI: 2.237, 8.820), P=0.001]. Subgroup analyses revealed that MLR's association with LOS in the ICU was influenced by IVH and treatments such as caffeine and mechanical ventilation, with mediation analysis confirming MLR as a mediator in these contexts.
Conclusions: MLR is significantly associated with increased LOS in the ICU among neonates with apnea, with treatment factors modifying this relationship.
Keywords: Neonatal apnea; clinical outcome; intensive care unit (ICU); lymphocyte; monocyte.
Copyright © 2025 AME Publishing Company. All rights reserved.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-2025-21/coif). The authors have no conflicts of interest to declare.
Figures



Similar articles
-
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.Cochrane Database Syst Rev. 2003;(1):CD002052. doi: 10.1002/14651858.CD002052. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2012 Jun 13;(6):CD002052. doi: 10.1002/14651858.CD002052.pub2. PMID: 12535424 Updated.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.Cochrane Database Syst Rev. 2000;(2):CD002052. doi: 10.1002/14651858.CD002052. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(1):CD002052. doi: 10.1002/14651858.CD002052. PMID: 10796280 Updated.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Melatonin for the promotion of sleep in adults in the intensive care unit.Cochrane Database Syst Rev. 2018 May 10;5(5):CD012455. doi: 10.1002/14651858.CD012455.pub2. Cochrane Database Syst Rev. 2018. PMID: 29746721 Free PMC article.
References
-
- Martin RJ, Abu-Shaweesh JM, Baird TM. Apnoea of prematurity. Paediatr Respir Rev 2004;5 Suppl A:S377-82. - PubMed
LinkOut - more resources
Full Text Sources